One Nucleus presents Genesis 2024
December 3, 2024
Pharmidex
is thrilled to announce that
Ash Alavijeh, our Head of Operations, will attend the "Maximising Returns from Life Science Innovation" conference by One Nucleus on 4 December 2024, at 1 Wimpole Street, London, UK (https://lnkd.in/ea5abEEQ).
This dynamic event is a fantastic opportunity to explore life science breakthroughs and connect with industry leaders.
Ash is excited to meet attendees, exchange ideas, and discuss ways to innovate together. Don’t miss the chance to say hello!

#Pharmidex #LifeScienceInnovation #Networking #GenesisConference

At Pharmidex, we are proud to contribute to scientific innovation through robust and reliable bioanalytical support from early discovery to regulated studies. For over eight years, we've partnered with Shimadzu, using their LCMS-8060 and LC-2050 systems to deliver high-quality, data-driven results tailored to diverse client needs. Their instruments have played a key role in advancing our bioanalytical capabilities and supporting the success of our collaborative projects. Our Head of Operations, Ash Alavijeh , recently shared insights from our long-standing collaboration as part of Shimadzu’s 150th anniversary testimonial series. We are honored to be part of their journey and look forward to continuing this partnership built on shared values of precision, reliability, and innovation. 👉 Read more stories from the Shimadzu global community here .

At Pharmidex, we stand in solidarity with individuals and families affected by Huntington’s Disease a rare, inherited neurodegenerative condition that impacts the mind, body, and spirit. Throughout May, we reaffirm our commitment to advancing neuroscience research and supporting drug discovery efforts aimed at neurodegenerative diseases. Our team is proud to collaborate with partners working toward meaningful therapies that can improve quality of life and bring hope to the HD community. Let’s raise awareness. Let’s drive innovation. Let’s stand together.

We’re pleased to share that Mo Yaqoob from our Business Development team will be attending the C3 Summit on 8 May 2025 at 8 Northumberland Ave, London. 🔗 https://www.thec3summit.com/london-2025/  Mo is looking forward to meeting fellow attendees, exploring new partnerships, and discussing how we can work together to accelerate the development of innovative drug candidates. If you're attending, don’t hesitate to connect let’s spark the next great collaboration!